Atlas FDA

PERFLUOROPROPANE FOR PNEUMATIC RETINOPEXY

FDA premarket approval P900066/S003 · decided 2000-03-16

Approval details

PMA number
P900066
Supplement
S003
Supplement type
Normal 180 Day Track
Supplement reason
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
PERFLUOROPROPANE FOR PNEUMATIC RETINOPEXY
Generic name
Gases used within eye to place pressure on detached retina
Applicant
Airgas Therapeutics, LLC
Date received
1999-09-21
Decision date
2000-03-16
Days to decision
177 days
Decision code
APPR
Product code
LPO
Advisory committee
Ophthalmic
Expedited review
No
Location
Plumsteadville, PA
Statement
1)Change in manufacturing site; 2)Alternate synthesis route for perfluoropropane; and 3) Changing release specification for the perfluoropropane gas.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
ULSPIRA TS™ Nitric Oxide Therapy System (K242374)Airgas Therapeutics, LLC2025-01-17